Nectar Lifesciences informs about standalone financial results

23 Aug 2016 Evaluate

Nectar Lifesciences has informed about Standalone Financial Results, Limited Review for the period ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

34.00 -0.20 (-0.58%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.